These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17187753)

  • 21. Detection of aggrecanase- and MMP-generated catabolic neoepitopes in the rat iodoacetate model of cartilage degeneration.
    Janusz MJ; Little CB; King LE; Hookfin EB; Brown KK; Heitmeyer SA; Caterson B; Poole AR; Taiwo YO
    Osteoarthritis Cartilage; 2004 Sep; 12(9):720-8. PubMed ID: 15325638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of cartilage turnover. Part 1: Markers of collagen degradation and synthesis.
    Garvican ER; Vaughan-Thomas A; Innes JF; Clegg PD
    Vet J; 2010 Jul; 185(1):36-42. PubMed ID: 20488735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
    De Ceuninck F; Sabatini M; Renoux V; de Nanteuil G; Pastoureau P
    J Rheumatol; 2003 Jul; 30(7):1561-4. PubMed ID: 12858459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoaffinity liquid chromatography-tandem mass spectrometry detection of nitrotyrosine in biological fluids: development of a clinically translatable biomarker.
    Radabaugh MR; Nemirovskiy OV; Misko TP; Aggarwal P; Mathews WR
    Anal Biochem; 2008 Sep; 380(1):68-76. PubMed ID: 18539125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anatomical localization of cartilage degradation markers in a surgically induced rat osteoarthritis model.
    Wancket LM; Baragi V; Bove S; Kilgore K; Korytko PJ; Guzman RE
    Toxicol Pathol; 2005; 33(4):484-9. PubMed ID: 16036866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
    Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
    FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice.
    Sahebjam S; Khokha R; Mort JS
    Arthritis Rheum; 2007 Mar; 56(3):905-9. PubMed ID: 17328064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of an antineoepitope antibody for identification of type-II collagen degradation in equine articular cartilage.
    Billinghurst RC; Buxton EM; Edwards MG; McGraw MS; McIlwraith CW
    Am J Vet Res; 2001 Jul; 62(7):1031-9. PubMed ID: 11453476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification.
    Kamphorst JJ; van der Heijden R; DeGroot J; Lafeber FP; Reijmers TH; van El B; Tjaden UR; van der Greef J; Hankemeier T
    J Proteome Res; 2007 Nov; 6(11):4388-96. PubMed ID: 17929855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis.
    Laverty S; Okouneff S; Ionescu M; Reiner A; Pidoux I; Webber C; Rossier Y; Billinghurst RC; Poole AR
    J Orthop Res; 2002 Nov; 20(6):1282-9. PubMed ID: 12472241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a neutralizing antibody specific for the active form of matrix metalloproteinase-13.
    Naito S; Takahashi T; Onoda J; Yamauchi A; Kawai T; Kishino J; Yamane S; Fujii I; Fukui N; Numata Y
    Biochemistry; 2012 Nov; 51(44):8877-84. PubMed ID: 23050690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy.
    Berna M; Ott L; Engle S; Watson D; Solter P; Ackermann B
    Anal Chem; 2008 Feb; 80(3):561-6. PubMed ID: 18179251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY; Stabler TV; Criscione LG; Elliott AL; Jordan JM; Kraus VB
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis.
    Vinardell T; Dejica V; Poole AR; Mort JS; Richard H; Laverty S
    Osteoarthritis Cartilage; 2009 Mar; 17(3):375-83. PubMed ID: 18809344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis.
    Sandya S; Sudhakaran PR
    Exp Biol Med (Maywood); 2007 May; 232(5):629-37. PubMed ID: 17463159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog.
    Chu Q; Lopez M; Hayashi K; Ionescu M; Billinghurst RC; Johnson KA; Poole AR; Markel MD
    Osteoarthritis Cartilage; 2002 Aug; 10(8):662-9. PubMed ID: 12479389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation.
    Morquette B; Shi Q; Lavigne P; Ranger P; Fernandes JC; Benderdour M
    Arthritis Rheum; 2006 Jan; 54(1):271-81. PubMed ID: 16385544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
    Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
    Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.